Elizabeth Fagan

931 total citations
18 papers, 690 citations indexed

About

Elizabeth Fagan is a scholar working on Cognitive Neuroscience, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, Elizabeth Fagan has authored 18 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cognitive Neuroscience, 3 papers in Surgery and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Elizabeth Fagan's work include Neuroscience of respiration and sleep (3 papers), Neonatal and fetal brain pathology (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Elizabeth Fagan is often cited by papers focused on Neuroscience of respiration and sleep (3 papers), Neonatal and fetal brain pathology (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Elizabeth Fagan collaborates with scholars based in Australia, United Kingdom and Canada. Elizabeth Fagan's co-authors include Cathy J. Price, Mohamed L. Seghier, Margot J. Taylor, Jayne Antony, Russell C. Dale, Fabienne Brilot, John Earl, David Sillence, Colin E. Sullivan and Karen A. Waters and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and European Respiratory Journal.

In The Last Decade

Elizabeth Fagan

17 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Fagan Australia 13 267 139 117 74 73 18 690
Hugo R Van Dongen Netherlands 14 239 0.9× 106 0.8× 121 1.0× 116 1.6× 42 0.6× 39 872
Gösta Blennow Sweden 20 332 1.2× 263 1.9× 140 1.2× 147 2.0× 65 0.9× 32 1.1k
Malin Maeder‐Ingvar Switzerland 15 248 0.9× 346 2.5× 120 1.0× 36 0.5× 55 0.8× 30 707
Thomas F. Flood United States 13 99 0.4× 53 0.4× 131 1.1× 80 1.1× 63 0.9× 19 782
Nivedita Agarwal Italy 13 279 1.0× 133 1.0× 117 1.0× 30 0.4× 61 0.8× 45 677
Stephen McGuire United States 16 193 0.7× 37 0.3× 208 1.8× 45 0.6× 90 1.2× 31 855
David Rosenberg United States 14 427 1.6× 319 2.3× 52 0.4× 44 0.6× 55 0.8× 23 998
Robert D. Nass Germany 19 206 0.8× 315 2.3× 109 0.9× 47 0.6× 74 1.0× 35 1.1k
Henri B. Szliwowski Belgium 14 83 0.3× 85 0.6× 89 0.8× 52 0.7× 73 1.0× 31 662
Michael Maier United Kingdom 14 342 1.3× 296 2.1× 41 0.4× 31 0.4× 52 0.7× 27 862

Countries citing papers authored by Elizabeth Fagan

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Fagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Fagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Fagan more than expected).

Fields of papers citing papers by Elizabeth Fagan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Fagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Fagan. The network helps show where Elizabeth Fagan may publish in the future.

Co-authorship network of co-authors of Elizabeth Fagan

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Fagan. A scholar is included among the top collaborators of Elizabeth Fagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Fagan. Elizabeth Fagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Costabel, Ulrich, Carlo Albera, Elizabeth Fagan, et al.. (2014). Long-term safety of pirfenidone in RECAP, an open-label extension study in patients with idiopathic pulmonary fibrosis, interim results. European Respiratory Journal. 44(Suppl 58). 1903–1903. 2 indexed citations
2.
King, Talmadge E., Williamson Z. Bradford, Elizabeth Fagan, et al.. (2014). Effect of design modifications on trial outcomes in idiopathic pulmonary fibrosis (IPF): Analysis of data from ASCEND and CAPACITY (CAP). 44. 4629. 1 indexed citations
3.
Symmonds, Mkael, Nicole C. Wright, Elizabeth Fagan, & Raymond J. Dolan. (2013). Assaying the Effect of Levodopa on the Evaluation of Risk in Healthy Humans. PLoS ONE. 8(7). e68177–e68177. 11 indexed citations
4.
Seghier, Mohamed L., Elizabeth Fagan, & Cathy J. Price. (2010). Functional Subdivisions in the Left Angular Gyrus Where the Semantic System Meets and Diverges from the Default Network. Journal of Neuroscience. 30(50). 16809–16817. 209 indexed citations
5.
Dale, Russell C., Fabienne Brilot, Elizabeth Fagan, & John Earl. (2009). Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation. Developmental Medicine & Child Neurology. 51(4). 317–323. 72 indexed citations
6.
MacLennan, Suzanna C., et al.. (2008). High-Dose Ribof lavin for Migraine Prophylaxis in Children: A Double-Blind, Randomized, Placebo-Controlled Trial. Journal of Child Neurology. 23(11). 1300–1304. 65 indexed citations
7.
Johnston, Ian H., John Duff, Erica Jacobson, & Elizabeth Fagan. (2001). Asymptomatic Intracranial Hypertension in Disorders of CSF Circulation in Childhood – Treated and Untreated. Pediatric Neurosurgery. 34(2). 63–72. 17 indexed citations
8.
Fagan, Elizabeth, et al.. (2000). Two novel polymorphisms (E277K and V212V) in the haemochromatosis gene HFE. Human Mutation. 15(1). 120–120. 12 indexed citations
9.
Grattan‐Smith, Padraic J., et al.. (2000). The Value of Partial Sleep Deprivation as a Routine Measure in Pediatric Electroencephalography. Journal of Child Neurology. 15(1). 26–29. 48 indexed citations
10.
Zafeiriou, Dimitrios, et al.. (1999). Protracted course of N-acetylaspartic aciduria in two non-Jewish siblings: identical clinical and magnetic resonance imaging findings. Brain and Development. 21(3). 205–208. 17 indexed citations
11.
Fagan, Elizabeth & Stewart J. Payne. (1999). A novel missense mutation S65C in the HFE gene with a possible role in hereditary haemochromatosis. Human Mutation. 13(6). 507–508.
12.
Waters, Karen A., et al.. (1995). Treatment of obstructive sleep apnea in achondroplasia: Evaluation of sleep, breathing, and somatosensory‐evoked potentials. American Journal of Medical Genetics. 59(4). 460–466. 38 indexed citations
13.
North, Kathryn N., et al.. (1994). Optic gliomas in neurofibromatosis type 1: Role of visual evoked potentials. Pediatric Neurology. 10(2). 117–123. 42 indexed citations
14.
Waters, Karen A., et al.. (1993). Breathing abnormalities in sleep in achondroplasia.. Archives of Disease in Childhood. 69(2). 191–196. 48 indexed citations
15.
Ouvrier, Robert, et al.. (1992). ACTH treatment in intractable seizures of childhood. Brain and Development. 14(2). 102–106. 10 indexed citations
16.
Taylor, Margot J. & Elizabeth Fagan. (1988). SEPs to median nerve stimulation: normative data for paediatrics. Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section. 71(5). 323–330. 53 indexed citations
17.
Fagan, Elizabeth, et al.. (1987). Somatosensory evoked potentials: Part II. A review of the clinical applications in pediatric neurology. Pediatric Neurology. 3(5). 249–255. 19 indexed citations
18.
Fagan, Elizabeth, Michael J. Taylor, & W. P. D. Logan. (1987). Somatosensory evoked potentials: Part I. A review of neural generators and special considerations in pediatrics☆. Pediatric Neurology. 3(4). 189–196. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hugo R Van Dongen Breakdown of academic impact, for papers by Gösta Blennow Breakdown of academic impact, for papers by Malin Maeder‐Ingvar Breakdown of academic impact, for papers by Thomas F. Flood Breakdown of academic impact, for papers by Nivedita Agarwal Breakdown of academic impact, for papers by Stephen McGuire Breakdown of academic impact, for papers by David Rosenberg Breakdown of academic impact, for papers by Robert D. Nass Breakdown of academic impact, for papers by Henri B. Szliwowski Breakdown of academic impact, for papers by Michael Maier
Rankless by CCL
2026